“Broad spectrum” antidepressants: Is more better for the treatment of depression?
- 26 September 2003
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 73 (25) , 3175-3179
- https://doi.org/10.1016/j.lfs.2003.06.007
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitorEuropean Journal of Pharmacology, 2003
- Lower dopamine transporter binding potential in striatum during depressionNeuroReport, 2001
- Current perspectives on the development of non-biogenic amine-based antidepressantsPharmacological Research, 2001
- Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depressionJournal of Affective Disorders, 2000
- The role of dopamine in the mechanism of action of antidepressant drugsEuropean Journal of Pharmacology, 2000
- Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatmentsMolecular Psychiatry, 2000
- Comparison of pramipexole, fluoxetine, and placebo in patients with major depressionDepression and Anxiety, 2000
- Pramipexole Augmentation in the Treatment of Unipolar and Bipolar Depression: A Retrospective Chart ReviewAnnals of Clinical Psychiatry, 2000
- Functional antagonists at the NMDA receptor complex exhibit antidepressant actionsEuropean Journal of Pharmacology, 1990
- Is the forced swimming test a suitable model for revealing antidepressant activity?Psychopharmacology, 1988